<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> antibody syndrome (APS) is characterized by <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:mp ids='MP_0005048'>thrombosis</z:mp> and/or abortion </plain></SENT>
<SENT sid="1" pm="."><plain>Steroid and aspirin therapy has been reported useful for <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">habitual abortion</z:e> associated with APS </plain></SENT>
<SENT sid="2" pm="."><plain>Eleven patients, whose prior pregnancies resulted in <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">habitual abortion</z:e> (41 abortions), were received a intentional <z:chebi fb="2" ids="8378">prednisolone</z:chebi> (40 mg/day) and aspirin (81 mg/day) therapy before further pregnancies and both agents were decreased gradually </plain></SENT>
<SENT sid="3" pm="."><plain>We maintained <z:chebi fb="2" ids="8378">prednisolone</z:chebi> (10-15 mg/day) and aspirin (40.5 mg/day) during pregnancy period </plain></SENT>
<SENT sid="4" pm="."><plain>After the treatment, the outcome of pregnancy was successful in 7 of 10 pregnancies </plain></SENT>
<SENT sid="5" pm="."><plain>The weight of newborn infants ranged from 1980 to 2980 g and apgar score ranged from 4 to 9 points </plain></SENT>
<SENT sid="6" pm="."><plain>No side effect was observed, and fetal malformation and/or <z:hpo ids='HP_0000846'>adrenal insufficiency</z:hpo> was not recognized in any infants </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, an intentional <z:chebi fb="2" ids="8378">prednisolone</z:chebi> plus aspirin therapy is useful to prevent <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">habitual abortion</z:e> in patient with APS </plain></SENT>
</text></document>